Thomas B. Smith MD - 10 Feb 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Reporting relationship: EVP and Chief Medical Officer
Issuer ticker: COLL
Reported as of: 10 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Feb 2023, 16:19:23 UTC
Prior SEC filing: 01 Apr 2022
Next SEC filing: 14 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Colleen Tupper as Attorney-In-Fact For Thomas B. Smith, MD

Key filing fact

Thomas B. Smith MD filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 14 Feb 2023.

Key facts

This page summarizes Thomas B. Smith MD's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Feb 2023, 16:19.

Change

Previous filing in this sequence was filed on 01 Apr 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COLL transaction

Common Stock

Award

Transaction value: $0
Shares: +31,185
Change %
Price: $0.000000
Shares after: 31,185
Date: 10 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.